trending Market Intelligence /marketintelligence/en/news-insights/trending/laougdzdl5lmquspmn_law2 content esgSubNav
In This List

Dawnrays Pharmaceutical nonexecutive director retires; replacement named

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Dawnrays Pharmaceutical nonexecutive director retires; replacement named

Dawnrays Pharmaceutical (Holdings) Ltd. said Choi Tat Ying Jacky retired as an independent nonexecutive director to focus on personal endeavors.

Furthermore, the Hong Kong-based drugmaker named Lam Ming Yee Joan an independent nonexecutive director.

Lam is a certified public accountant and the spouse of former director Choi. Dawnrays Pharmaceutical said Lam meets the regulatory guidelines for independence.